Tuesday, September 17, 2002 1:06:15 PM
13:03 ET Bristol-Myers reaffirms 2002 guidance, inventory workdown on track (BMY) 25.60 -0.35: Reaffirms 2002 EPS guidance of $1.69-$1.81; co also confirmed its previous estimates that the domestic wholesaler inventory workdown will reduce diluted EPS by a total of about $0.61, and that nearly 90% of the total workdown impact will be achieved by year-end 2002, with avg inventory for the co's exclusive products at year end at or near desirable levels.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
